- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01726543
Safety and Efficacy of Canaloplasty and Non-penetrating Deep Sclerectomy With Phacoemulsification to Treat Glaucoma and Cataract
Comparison of Safety and Efficacy of Canaloplasty and Non-penetrating Deep Sclerectomy Combined With Phacoemulsification to Treat Glaucoma and Cataract. A Randomised, Prospective Study.
Study Overview
Status
Conditions
Study Type
Enrollment (Anticipated)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Warsaw, Poland, 04-141
- Recruiting
- Military Institute of Medicine
-
Contact:
- Anna Byszewska, MD
- Phone Number: +48 500285890
- Email: ania.byszewska@gmail.com
-
Contact:
- Marek Rekas, MD, PhD Associate Professor of
- Phone Number: +48 226816575
- Email: rekaspl@gmail.com
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- co-existing glaucoma and cataract
- glaucoma types ( open angle glaucoma,pseudoexfoliation syndrome, pigmentary glaucoma)
- eye with characteristic glaucoma changes (biomicroscopic,visual field) with IOP >16mmHg on medication or without, or IOP<16mmHg on 2 or more medications.
- uncontrolled IOP
- patients not tolerating antiglaucoma medications,
- patients with poor compliance
- progression in visual field
Exclusion Criteria:
- previous surgical glaucoma procedure
- previous cataract surgery
- visual function under 0,004
- closed angle glaucoma
- poorly controlled diabetes mellitus
- advanced AMD
- active inflammatory disease
- pregnancy
- mental disease or emotional instability, that could
Study Plan
How is the study designed?
Design Details
- Primary Purpose: TREATMENT
- Allocation: RANDOMIZED
- Interventional Model: PARALLEL
- Masking: SINGLE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
ACTIVE_COMPARATOR: Canaloplasty and phacoemulsification
|
As soon as the two scleral flaps (deep and superficial -similar to deep sclerectomy) are dissected, the phacoemulsification is performed and a artificial lense is implanted.
After excision of the deep flap the descemets window and ostia of Schlemm canal are created, the microcatheter is placed in the canal and is advanced 12 clock hours within the canal.
Surgeon observes the location of beacon tip through sclera and injects the Healon GV.
When the catheterisation of the canal is done, the distal tip is exposed and a 10-0 propylene suture is tied to the distal tip.
Then the microcatheter is withdrawn and suture is pulled into the canal.
As it appears at the other ostium of canal the microcatheter it separated from the suture.
A loop is created, encircling the inner wall of Schlemm canal.
Then suture loop is tightened to distend the trabecular meshwork inward, placing the tissues in tension, the locking nods are added.
The superficial flap is sutured watertight to prevent bleb formation.
|
|
ACTIVE_COMPARATOR: Non-penetrating deep sclerectomy and phacoemulsification
|
A fornix-based conjunctival flap is dissected superiorly, and the sclera is exposed.
A 5 x 5 mm scleral flap is dissected anteriorly into clear cornea using a No. 69 Beaver blade.
Then the phacoemulsification procedure is performed and a artificial lense is implanted.
Afterwards second deep scleral flap is dissected and excised leaving only a thin layer of deep sclera over the choroid.
Anteriorly, the dissection is made down to remove Schlemm's canal and juxtacanalicular trabeculum.
Excision of the corneal stroma is performed more anteriorly down to Descemet's membrane.
This allows aqueous humor to percolate through the thin trabecular-Descemet's membrane.
The superficial scleral flap is then closed with two 10-0 monofilament nylon sutures.The conjunctiva is sutured down over the limbus with one interrupted 10-0 monofilament nylon suture at each corner.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
IOP
Time Frame: Change from Baseline at 24months
|
by Goldman tonometry Primary efficacy outcome-proportion of the population that achieves an IOP of >5 and ≤ 21 mmHg, irrespective of glaucoma medication use. Complete success is defined as achieving the target IOP without use of medications. A qualified success is defined as achieving the target IOP with either no change in medications or a reduction in medication as compared to that used preoperatively. |
Change from Baseline at 24months
|
|
number of antiglaucoma medications
Time Frame: Change from Baseline at 24months
|
Change from Baseline at 24months
|
|
|
visual acuity
Time Frame: Change from Baseline at 24months
|
ETDRS chart
|
Change from Baseline at 24months
|
|
intraoperative complications
Time Frame: surgery day
|
Rates for surgical complications and adverse events
|
surgery day
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Secondary procedures
Time Frame: within 24 months
|
Any additional ophtalmic surgical procedures that need to be done within the time frame.
|
within 24 months
|
|
Early and late complications
Time Frame: within 24 months
|
complications and Adverse effects rate
|
within 24 months
|
Collaborators and Investigators
Investigators
- Study Director: Marek Rekas, MD,PhD,Professor, Military Institute of Medicine, Poland
Study record dates
Study Major Dates
Study Start
Primary Completion (ANTICIPATED)
Study Completion (ANTICIPATED)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (ESTIMATE)
Study Record Updates
Last Update Posted (ESTIMATE)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- BW1 151/12
- BW1151/12 (OTHER: MMIPoland)
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Cataract
-
Colvard Kandavel Eye CenterEnrolling by invitationCataract | Cataract Bilateral | Cataract Surgery | Cataract (Post-operative Cataract Surgery Follow-up)United States
-
Matthew RauenNot yet recruitingNuclear Cataract | Cataract Surgery Anesthesia | Cataract and IOL Surgery | Cataract Surgery ExperienceUnited States
-
Züleyha SönmezAtaturk UniversityActive, not recruitingCataract Surgery | Cataract Patients | Cataract After SurgeryTurkey (Türkiye)
-
Stanford UniversityEnrolling by invitationIntraocular Lens | Cataract Extraction | Cataract Surgery | Eye Disorders | Cataract and IOL Surgery | Cataract Surgery ExperienceUnited States
-
Gemini Eye ClinicRecruitingBilateral Cataract | Unilateral CataractCzechia
-
Fundación Pública Andaluza para la Investigación...CompletedCataract | Cataract Mature | Cataract, Nuclear
-
Seva Canada SocietyPragyaan Sustainable Health Outcomes Foundation; Sadgura Netra ChikitsalayaNot yet recruitingCataract (Post-operative Cataract Surgery Follow-up)
-
Nicole Fram M.D.RecruitingCataract Bilateral | Nuclear Sclerosis of the Lens | Phacoemulsification Cataract SurgeryUnited States
-
Johannes Kepler University of LinzCompletedCataract Complicated | Cataract Complications OperationsAustria
-
Universitaire Ziekenhuizen KU LeuvenLaboratoires TheaRecruiting
Clinical Trials on Canaloplasty and phacoemulsification
-
Military Institute of Medicine, PolandUnknownPrimary Open Angle Glaucoma, CataractPoland
-
Nova Eye, Inc.Nova Eye Medical GmbHRecruitingPrimary Open Angle GlaucomaGermany, United States
-
New World Medical, Inc.RecruitingOAG - Open-Angle GlaucomaCosta Rica, Chile, Honduras
-
New World Medical, Inc.Completed
-
Nova Eye, Inc.Nova Eye Medical GmbHRecruitingPrimary Open Angle GlaucomaUnited Kingdom, Germany, Spain
-
University Tunis El ManarCompletedEffect of Cataract Surgery on Corneal Endothelium; About 2 TechniquesTunisia
-
Medical University of BialystokMedical University of LublinRecruiting
-
State University of New York at BuffaloCompletedGlaucomaUnited States
-
Ridge Eye CareAlcon ResearchActive, not recruitingGlaucoma, Open-AngleUnited States